Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial
Co-administration of vaccines could be an efficient strategy to increase vaccination uptake and reduce the number of clinic visits. This randomized controlled study aimed to evaluate the immunogenicity and safety of enterovirus 71 (EV71) vaccine co-administered with measles-mumps-rubella (MMR) vacci...
Saved in:
Main Authors: | Xiaoyu Liu (Author), Wanqi Yang (Author), Chao Zhang (Author), Heng Wu (Author), Ruize Wang (Author), Qiang Ding (Author), Yan Hu (Author), Yongli Xiong (Author), Shaobai Zhang (Author), Lin Wang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mumps, Measles and Rubella Vaccination and Encephalitis
by: J Gordon Millichap
Published: (1989) -
Inactivated enterovirus A71 vaccines and moving forward
by: Hiroyuki Shimizu
Published: (2021) -
Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000) -
Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial
by: Yajun Shu, et al.
Published: (2024) -
Science vs ''scaremongering'' over measles-mumps-rubella vaccine
by: Jacqui Wise
Published: (2001)